Agarwal Fortune India Limited (BOM:530765)
India · Delayed Price · Currency is INR 23.50
0.00 (0.00%)
At close: May 25, 2026
Agarwal Fortune India Revenue
In the fiscal year ending March 31, 2026, Agarwal Fortune India had annual revenue of 56.31M INR with 25.57% growth. Agarwal Fortune India had revenue of 4.27M in the quarter ending March 31, 2026, a decrease of -81.66%.
Revenue
56.31M
Revenue Growth
+25.57%
P/S Ratio
1.42
Revenue / Employee
28.16M
Employees
2
Market Cap
80.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 56.31M | 11.47M | 25.57% |
| Mar 31, 2025 | 44.85M | -30.55M | -40.52% |
| Mar 31, 2024 | 75.40M | 23.61M | 45.58% |
| Mar 31, 2023 | 51.79M | 49.59M | 2,254.14% |
| Mar 31, 2022 | 2.20M | 1.34M | 155.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karnawati Innovation | 919.30M |
| Dhanvantri Jeevan Rekha | 244.50M |
| Finelistings Technologies | 118.76M |
| Shiva Suitings | 16.92M |
| Genomic Valley Biotech | 4.94M |
| Bhagawati Oxygen | 4.89M |
| Indo Credit Capital | 2.75M |
| Rich Universe Network | -39.74K |